Jounce Therapeutics, Inc. JNCE Balance Sheet

Jounce therapeutics, inc. (JNCE)

Balance Sheet / Yearly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16
Assets:
Current assets:
Cash and cash equivalents
74,991	53,241	66,402	37,994	40,172	47,906	53,283	50,109	122,805	23,559	28,634	43,482	61,991	44,848
Short-term investments
71,975	115,602	109,398	114,026	123,617	141,968	158,476	182,602	114,370	212,093	222,457	227,321	200,263	104,410
Prepaid expenses and other current assets
5,393	4,854	5,253	5,328	6,095	2,335	2,606	2,619	20,432	19,945	8,727	8,513	4,166	2,529
Total current assets
152,359	173,697	181,053	157,348	169,884	192,209	214,365	235,330	257,607	255,597	259,818	279,316	266,420	151,787
Property and equipment, net
9,755	10,672	11,588	12,148	12,678	13,540	14,239	15,143	15,842	16,151	16,323	15,507	13,859	7,241
Long-term investments
1,608	1,601	9,297	0	9,455	5,990	2,969	0	0	22,199	32,305	39,086	77,707	108,116
Operating lease right-of-use asset
16,946	17,615	18,269	18,911	19,540	-	-	-	-	-	-	-	-	-
Other non-current assets
2,282	2,297	2,151	2,197	1,652	2,713	2,663	2,682	2,668	2,713	8,595	2,535	2,836	4,168
Total assets
182,950	205,882	222,358	190,604	213,209	214,452	234,236	253,155	276,117	296,660	317,041	336,444	360,822	271,312
Liabilities and stockholders’ equity:
Current liabilities:
Accounts payable
3,722	2,460	3,408	2,596	4,032	3,272	2,910	2,990	5,539	2,849	4,379	3,104	5,711	3,511
Accrued expenses
7,543	8,907	7,032	7,344	5,995	6,952	7,779	6,986	5,964	8,454	5,552	6,411	4,359	5,855
Deferred rent and lease incentive, current
-	-	-	-	-	-	61	61	61	61	61	61	790	720
Deferred revenue, current—related party
-	-	0	64,879	62,927	55,157	58,947	55,553	-	51,142	-	-	-	-
Operating lease liability, current
2,991	2,901	2,814	2,729	2,645	-	-	-	-	-	-	-	-	-
Deferred revenue, currentrelated party
-	-	-	-	-	-	-	-	59,020	-	51,957	69,235	76,663	80,544
Other current liabilities
39	132	54	47	120	165	57	91	373	45	900	49	45	43
Total current liabilities
14,295	14,400	13,308	77,595	75,719	65,546	69,754	65,681	70,957	62,551	62,849	78,860	87,568	90,673
Deferred rent and lease incentive, net of current portion
-	-	-	-	-	-	2,040	2,018	1,996	1,955	1,904	1,854	2,209	1,452
Deferred revenue, net of current portion—related party
-	-	0	4,566	23,964	42,715	59,025	76,947	-	65,018	-	-	-	-
Operating lease liability, net of current portion
16,111	16,889	17,641	18,379	19,102	-	-	-	-	-	-	-	-	-
Deferred revenue, net of current portionrelated party
-	-	-	-	-	-	-	-	92,858	-	77,192	77,990	90,851	107,260
Other non-current liabilities
-	-	0	0	0	2,062	7	14	20	27	34	41	48	56
Total liabilities
30,406	31,289	30,949	100,540	118,785	110,323	130,826	144,660	165,831	129,551	141,979	158,745	180,676	199,441
Commitments and contingencies
-	-	-	-	-	-	0	0	0	-	0	0	0	0
Stockholders’ equity:
Preferred stock, $0.001 par value: 5,000 shares authorized at March 31, 2020 and December 31, 2019; no shares issued or outstanding at March 31, 2020 or December 31, 2019
0	0	0	0	0	0	0	0	0	0	0	0	0	0
Common stock, $0.001 par value: 160,000 shares authorized at March 31, 2020 and December 31, 2019; 34,049 and 33,738 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively
34	34	33	33	33	33	33	33	32	32	32	32	32	2
Additional paid-in capital
285,968	281,664	275,790	273,248	270,699	268,081	265,384	262,908	260,161	257,101	255,625	252,195	251,196	4,515
Accumulated other comprehensive income
144	54	78	135	51	-78	-140	-216	-351	-409	-344	-552	-486	-433
Accumulated deficit
-133,602	-107,159	-84,492	-183,352	-176,359	-163,907	-161,867	-154,230	-149,556	-89,615	-80,251	-76,167	-72,787	-73,172
Total stockholders’ equity
152,544	174,593	191,409	90,064	94,424	104,129	103,410	108,495	110,286	167,109	175,062	175,508	177,955	-69,088
Total liabilities and stockholders’ equity
182,950	205,882	222,358	190,604	213,209	214,452	234,236	253,155	276,117	296,660	317,041	336,444	360,822	271,312